- $240.98m
- $216.61m
- $20.22m
Annual balance sheet for Mediwound, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 21.4 | 11 | 33.9 | 41.7 | 43.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.84 | 2.27 | 9.53 | 4.42 | 5.85 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 26.2 | 15 | 45.8 | 49.7 | 52.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.51 | 4.03 | 3.58 | 15.9 | 20.8 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 31.1 | 19.7 | 50 | 66.5 | 73.5 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.27 | 10.7 | 12.1 | 10.8 | 26.5 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 23.8 | 24.3 | 39.1 | 34.9 | 42.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 7.27 | -4.58 | 10.9 | 31.6 | 31.2 |
| Total Liabilities & Shareholders' Equity | 31.1 | 19.7 | 50 | 66.5 | 73.5 |
| Total Common Shares Outstanding |